Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery

European Journal of Medicinal Chemistry
2010.0

Abstract

The enzyme dihydroorotate dehydrogenase (DHODH) has been suggested as a promising target for the design of trypanocidal agents. We report here the discovery of novel inhibitors of Trypanosoma cruzi DHODH identified by a combination of virtual screening and ITC methods. Monitoring of the enzymatic reaction in the presence of selected ligands together with structural information obtained from X-ray crystallography analysis have allowed the identification and validation of a novel site of interaction (S2 site). This has provided important structural insights for the rational design of T. cruzi and Leishmania major DHODH inhibitors. The most potent compound (1) in the investigated series inhibits TcDHODH enzyme with Kiapp value of 19.28 μM and possesses a ligand efficiency of 0.54 kcal mol(-1) per non-H atom. The compounds described in this work are promising hits for further development.

Knowledge Graph

Similar Paper

Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery
European Journal of Medicinal Chemistry 2010.0
Inhibitors ofTrypanosoma cruziTrypanothione Reductase Revealed by Virtual Screening and Parallel Synthesis
Journal of Medicinal Chemistry 2005.0
Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents
Bioorganic & Medicinal Chemistry 2009.0
Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening
Bioorganic & Medicinal Chemistry Letters 2009.0
The structure-based design and synthesis of selective inhibitors of trypanosoma cruzi dihydrofolate reductase
Bioorganic & Medicinal Chemistry Letters 1999.0
Synthesis, Biological Evaluation, and Structure–Activity Relationships of Potent Noncovalent and Nonpeptidic Cruzain Inhibitors as Anti-Trypanosoma cruzi Agents
Journal of Medicinal Chemistry 2014.0
Discovery of Diverse Human Dihydroorotate Dehydrogenase Inhibitors as Immunosuppressive Agents by Structure-Based Virtual Screening
Journal of Medicinal Chemistry 2012.0
Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents
Bioorganic & Medicinal Chemistry 2010.0
Novel Selective and Potent Inhibitors of Malaria Parasite Dihydroorotate Dehydrogenase: Discovery and Optimization of Dihydrothiophenone Derivatives
Journal of Medicinal Chemistry 2013.0
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies PotentPlasmodium falciparumDihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Journal of Medicinal Chemistry 2011.0